0001183740-22-000165.txt : 20220914 0001183740-22-000165.hdr.sgml : 20220914 20220914172613 ACCESSION NUMBER: 0001183740-22-000165 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220914 DATE AS OF CHANGE: 20220914 EFFECTIVENESS DATE: 20220914 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BRIGHT MINDS BIOSCIENCES INC. CENTRAL INDEX KEY: 0001827401 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-458931 FILM NUMBER: 221243794 BUSINESS ADDRESS: STREET 1: 19 VESTRY STREET CITY: NEW YORK STATE: NY ZIP: 10013 BUSINESS PHONE: 6474072515 MAIL ADDRESS: STREET 1: 19 VESTRY STREET CITY: NEW YORK STATE: NY ZIP: 10013 D 1 primary_doc.xml X0708 D LIVE 0001827401 BRIGHT MINDS BIOSCIENCES INC. 19 VESTRY STREET NEW YORK NY NEW YORK 10013 6474072515 BRITISH COLUMBIA, CANADA 1210954 BC Ltd. None Corporation true 2019 Ian McDonald 19 VESTRY STREET NEW YORK NY NEW YORK 10013 Executive Officer Director Chief Executive Officer and President Ryan Cheung 19 VESTRY STREET NEW YORK NY NEW YORK 10013 Executive Officer Chief Financial Officer Douglas Williamson 19 VESTRY STREET NEW YORK NY NEW YORK 10013 Director Revati Shreeniwas 19 VESTRY STREET NEW YORK NY NEW YORK 10013 Executive Officer Chief Medical Officer Jeremy Fryzuk 19 VESTRY STREET NEW YORK NY NEW YORK 10013 Director Jan Torleif Pedersen 19 VESTRY STREET NEW YORK NY NEW YORK 10013 Executive Officer Director Interim Chief Science Officer Nils Bottler 19 VESTRY STREET NEW YORK NY NEW YORK 10013 Director Biotechnology Decline to Disclose 06b false 2022-09-06 true true true false 0 149784 0 149784 Total Offering Amount represents the exercise price of the options (80,000 options @ C$2.46), converted to US$. There is no guarantee the options will be exercised. false 1 0 0 0 false BRIGHT MINDS BIOSCIENCES INC. /s/ Ian McDonald Ian McDonald President and CEO 2022-09-14